QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Business Model Expected to Generate up to $3M in Incremental Revenue
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, recently announced the development of the ultra-potent antioxidant astaxanthin (“AsX”) as an extremely fine and uniform nanoemulsion. The nanoemulsions produced by its trademarked Ultra Shear Technology(TM) (“UST”) platform encapsulate AsX in extremely small oil droplets ranging in size from 30-60 nm in diameter. “The enhanced oral bioavailability of AsX corresponding to droplet size reduction is well-established and has been published. Pressure BioSciences anticipates the use of its technology will make it possible for nutraceutical companies to exercise greater control over their…